Cardiff Oncology 10K 2016 Annual report | CRDF Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abide, abstract, adenosine, aim, al, amassing, ATP, bargaining, Blue, bulk, carryover, causal, China, Chinese, clarification, clarify, clarifying, combat, complaint, complement, composed, confounding, contemporaneously, content, Corrupt, County, CSF, cup, dataset, deadliest, departure, depict, Discordant, discretionary, dissemination, diversification, dominant, driven, duty, electrophoretic, employed, Exit, explained, extrathoracic, FedMed, floating, Fortified, fraction, Fujii, fundraising, Galaxy, gap, Genotyping, great, guideline, Guradant, hourly, IASLC, inadvisable, insertion, insight, intra, intrathoracic, Invited, lawsuit, licensee, likelihood, lucrative, manuscript, methylation, Michigan, missed, mL, Multiplan, negotiate, Nerviano, Next™Collect, Next™Extract, nineteen, NOL, noninvasive, noninvasively, online, OnTarget, oral, osimertinib, PAMA, paper, pathway, penalty, PLK, PPA, presumption, prominent, rational, refund, repetitive, reproducibility, restructuring, Rutan, scan, scheme, Shield, shipping, solidify, son, Stark, straight, Stratose, sublease, substrate, thoracic, titled, TKI, transform, transient, triphosphate, Trovera, TTS, Tucker, unamortized, unreliable, unresectable, unrest, usage, UTS, vendor, virology, void, waging, week, Welch, William

Removed: acute, add, added, affiliated, anticipating, assigned, attack, automatically, automation, bidding, Biocept, book, break, capitalization, Capturing, characterization, charged, chronically, collaborating, College, commence, converted, decade, declined, demonstration, depreciable, digit, digital, dilemma, directly, diseased, divided, droplet, Duke, enterprise, Exact, exist, expiration, extending, extinguishment, favorably, fellow, formed, France, frequency, fulfillment, fundamental, genomic, Genoptix, Head, Hospital, illiquidity, initially, instability, interacting, invest, Jersey, Johnson, labcorp, MDACC, mix, MoPath, morbidity, mortality, myeloid, NOC, noted, nucleophosmin, originating, peer, permanent, pharmacogenomic, predominantly, prescribe, protein, Qiagen, qualify, Quest, recoverability, recoverable, regional, renewed, rough, safe, School, scope, simplicity, simultaneously, sizeable, slightly, source, stool, Strand, stratification, stratify, sublicensing, successive, succumb, territory, tier, transferred, unvested, USOR, validate, venture, Veridex, widespread

Cardiff Oncology (CRDF) 10-K2016 FY Annual report

Content analysis